1.Distribution of the muscarinic receptors and characterization in the brain of wistar rats and spontaneously hypertensive rats(SHR strain) by digital autoradiography.
In SOHN ; Myung Chul LEE ; Chang Soon KOH
Korean Journal of Nuclear Medicine 1993;27(1):28-34
No abstract available.
Autoradiography*
;
Brain*
;
Rats, Wistar*
;
Receptors, Muscarinic*
2.Receptors for murine monoclonal antibodies on the normal blood cells.
Joon Ki JUNG ; Myung Chul LEE ; Chang Soon KOH
Journal of the Korean Cancer Association 1993;25(2):252-260
No abstract available.
Antibodies, Monoclonal*
;
Blood Cells*
3.A clinical study on prematurity who received blood transfusion.
Chul Soon PARK ; Myung Ik LEE ; Soon Wha KIM ; Don Hee AHN
Journal of the Korean Pediatric Society 1993;36(10):1389-1394
A clinical study was made on 85 cases of prematurity under 37 weeks of gestational age who had history of blood transfusion during their admission at the National Medical Center from January 1989 to June 1992. The results were as follows: 1) Among 339 prematurity patients, 85 patients(25.1%) received blood transfusion once at least. 2) Male to female ratio was 1.13:1 and mean gestational age was 32.5 2.7weeks (range:25~36 weeks). 3) Most of blood transfusion(66/85 cases) were performed within first week of life. 4) 67 patients(78.8%) received blood transfusion 3 times or less. 5) Combined diseases were hyaline membrane disease(69.4%), jaundice(51.8%), sepsis(30.6%), PDA (14.1%), DIC (8.2%), pulmonary hemorrhage(7.1%), intraventricular hemorrhage (7.1%), pneumonia(7.1%) and hepatitis(4.7%). 6) Clinical manifestations at the time of blood transfusion were pallor (47.1%), decreased activity (44.7%), bradycardia (23.5%),apnea (21.2%), tachypnea (20.0%), lethargy (4.7%), poor weight gain (3.5%) and tachycardia (3.5%). 7) The values of hematocrit were significantly increased after transfusion(42.4 +/-7.2 vs 34.6 +/- 6.8vol%). 8) The episodes of bradycardia were significantly decreased after blood transfusion(0.09 +/- 0.39 vs 0.23+/- 0.78)while the episodes of apnea were not (0.15 +/-0.71 vs 0.27+/- 0.84).
Apnea
;
Blood Transfusion*
;
Bradycardia
;
Dacarbazine
;
Female
;
Gestational Age
;
Hematocrit
;
Hemorrhage
;
Humans
;
Hyalin
;
Lethargy
;
Male
;
Membranes
;
Pallor
;
Tachycardia
;
Tachypnea
;
Weight Gain
4.Modulation of the Host Antimicrobial Peptide (Human beta-defensin-1, -2) Expression of Vaginal Squamous Epithelial Cells with using 17beta-Estradiol and Progesterone.
Min Su KIM ; Yu Chan KIM ; Sang Chul KIM ; Soon Chul MYUNG
Korean Journal of Urology 2007;48(4):439-443
PURPOSE: In mammals, alphaand beta-defensins are antimicrobial peptides that are expressed in various epithelial and phagocytic cells. Human beta-defensin-1 and -2 (hBD-1, hBD-2) have recently been shown to be expressed in various epithelial cells. Vaginal mucosa can be a target of vaginitis and the site of uropathogens' colonization that precedes urinary tract infections. Therefore, innate host defense mediators like antimicrobial peptides in the vaginal mucosa are important. Estrogen and progesterone receptors have been shown to be expressed in the vaginal squamous epithelium. Sex hormones like estrogen and progesterone may cause vaginal atrophy or susceptibility to uropathogens. So, we performed this study to investigate the expression patterns of hBD-1 and -2 mRNA in vaginal squamous epithelium (VSE) with using lipopolysaccharide (LPS), 17beta-estradiol and progesterone. MATERIALS AND METHODS: Normal VSE cells that were retrieved from vaginal tissue during vaginoplasty were primarily cultured in keratinocyte growth medium and they we allowed to undergo their 3rd passage. Modulation of the expressions of hBD-1 and -2 mRNA by various stimuli (LPS 0.5microgram/ml, E2 2nM, P 1micrometer) was measured by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). RESULTS: HBD-1 and -2 were constitutively expressed in the normal VSE cell lines, but the hBD-2 expression was not significant. A marked increase of the constitutive expression of hBD-2 mRNA was observed upon stimulation with LPS, but not upon stimulation with E2. A moderate decrease of the constitutive expression of hBD-2 mRNA upon stimulation with LPS was observed with administering progesterone. CONCLUSIONS: These expressions of hBD-2 mRNA may have important roles in the innate host defense of the urogenital area. Artificial intake of progesterone may lead to susceptibility via a decrease of defensins.
Atrophy
;
beta-Defensins
;
Cell Line
;
Colon
;
Defensins
;
Epithelial Cells*
;
Epithelium
;
Estrogens
;
Gonadal Steroid Hormones
;
Humans
;
Keratinocytes
;
Mammals
;
Mucous Membrane
;
Peptides
;
Phagocytes
;
Polymerase Chain Reaction
;
Progesterone*
;
Receptors, Progesterone
;
Reverse Transcription
;
RNA, Messenger
;
Urinary Tract Infections
;
Vagina
;
Vaginitis
5.Effect on body weight control through behavior, diet, exercise therapy in obese patients.
Hye Soon PARK ; Young Sun JUNG ; En Su SHIN ; Myung Wha KIM ; Chul Jun KIM
Journal of the Korean Academy of Family Medicine 1993;14(4):250-257
No abstract available.
Body Weight*
;
Diet*
;
Exercise Therapy*
;
Humans
6.Characteristics of 18F fluorodeoxyglucose Uptake in Human Colon Cancer Cells.
Chang Soon KOH ; Myung Chul LEE ; June Key CHUNG ; Jae Min JEONG ; Chae Kyun KIM
Korean Journal of Nuclear Medicine 1997;31(3):381-387
Cancer tissues are characterized by increased glucose uptake. 18F-fluorodeoxyglucose(FDG), a glucose analogue is used for the diagnosis of cancer in PET studies. This study was aimed to compare the glucose uptake and glucose transporter l(GLUT1) expression in various human colon cancer cells. We measured FDG uptake by cell retention study and expression of GLUTI using Western blotting. Human colon cancer cells, SNU-C2A, SNU-C4 and SNU-C5, were used. The cells were incubated with 1micro Ci/ml of FDG in HEPES-buffered saline for one hour. The FDG uptake of SNU-C2A,SNU-C4 and SNU-C5 were 16.8+/-1.36, 12.3+/-5.55 and 61.0+/-2.17cpm/microgram of protein, respectively. Dose-response and time-course studies represent that FDG uptake of cancer cells were dose dependent and time dependent. The rate of FDG uptake of SNU-C2A, SNU-C4 and SNU-C5 were 0.29+/-0.03, 0.21+/-0.09 and 1.07+/-0.07cpm/min/microgram of protein, respectively. Western blot analysis showed that the GLUT1 expression of SNU-C5 was significantly higher than those of SNU-C2A and SNU-C4. These results represent that FDG uptake into human colon cancer cells are different from each other. In addition, FDG uptake and expression of CLUT1 are closely related in human colon cancer cells.
Blotting, Western
;
Colon*
;
Colonic Neoplasms*
;
Diagnosis
;
Glucose
;
Glucose Transport Proteins, Facilitative
;
Humans*
7.Quantative measurement of tumor-associated antigen by autoradiography.
June Key CHUNG ; Dong Soo LEE ; Myung Chul LEE ; Chang Soon KOH ; James C REYNOLDS
Journal of the Korean Cancer Association 1991;23(4):740-748
No abstract available.
Autoradiography*
9.Experimental Study of Disodium Etidronate for the Growth of MC3T3-E1 Osteoblastic Cell Line
Myung Chul YOO ; Jin Hwan AHN ; Jung Soo HAN ; Koong Hee CHO ; Byung Soon KIM
The Journal of the Korean Orthopaedic Association 1990;25(2):553-561
In the general, Disodium estdronate (EHDP) had effects of inhibition in bone resorption, dissolution of hydroxyapatite crystal and decreasing the turn over rate in Paget's disease. Clinically it is used as the drug of treatment for the osteoporosis, heterotropic ossificatiom and Paget's disease inspite of some, controvesies, but there is few article about the effect of EHDP on osteoblast. Authors tries to observe the effect of EHDP on osteoblast using the MC3T3-El osteoblast cell line which has very similar chrateristics with human osteoblast and evaluate the effect by the criteria of changes of morphology, number of osteoblast, and alkaline phosphatase activity. The results are obtained as following: l. EHDP has direct inhibitory effect on the proliferation of osteoblast. 2. EHDP increase the alkaline phosphatase activity in vitro.
Alkaline Phosphatase
;
Bone Resorption
;
Cell Line
;
Durapatite
;
Etidronic Acid
;
Humans
;
In Vitro Techniques
;
Osteoblasts
;
Osteoporosis